Legha Lotfollahi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Legha Lotfollahi has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ilad Alavi Darazam
Department of Infectious Diseases and Tropical Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications Amir Ahamd Nassiri
Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Tehran, Iran
1 shared publicationArman Ahmadzadeh
Department of Rheumatology, Loghman Hakim Hospital Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publicationAzam Rahimzadeh Kalaleh
Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Tehran, Iran
1 shared publicationFarid Javandoust Gharebagh
Infectious Diseases and Tropical Medicine Research Center Shahid Beheshti University of Medical Sciences Tehran Iran
1 shared publication- Farid Javandoust Gharehbagh
Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
1 shared publication
Latest Publications
- Open Access
- 14 February 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (2)
Acute Acalculous Cholecystitis as the First Manifestation of Systemic Lupus Erythematosus in a Young Man: A Case Report and Review of Literature
Acute acalculous cholecystitis can rarely be the initial manifestation of systemic lupus erythematosus. Awareness of this atypical presentation is essential to avoid unnecessary surgical intervention. Prompt recognition and initiation of immunosuppressive therapy may resolve symptoms and help establish the correct underlying diagnosis.
- 14 February 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (2)
Open AccessAcute Acalculous Cholecystitis as the First Manifestation of Systemic Lupus Erythematosus in a Young Man: A Case Report and Review of Literature
Acute acalculous cholecystitis can rarely be the initial manifestation of systemic lupus erythematosus. Awareness of this atypical presentation is essential to avoid unnecessary surgical intervention. Prompt recognition and initiation of immunosuppressive therapy may resolve symptoms and help establish the correct underlying diagnosis.
- Open Access
- 1 April 2025
- Published by SAGE Publications in Science Progress
- Vol. 108 (2)
The correlation of perirenal fat and atherosclerosis: A systematic review and meta-analysis
Objective: Finding accessible diagnostic tools for the diagnosis of atherosclerosis is necessary due to its rising incidence rate. The correlation of perirenal fat thickness (PRFT) and atherosclerosis has been investigated in previous studies using different imaging modalities including ultrasound and CT-scan, but their results have been equivocal. Therefore, we performed a systematic review and meta-analysis of observational studies to determine this potential correlation. Methods: This study is a systematic review and meta-analysis of observational studies. A comprehensive search was conducted up to 2 July 2024, across articles published in the Scopus, Web of Science, Cochrane Library, and PubMed databases. The protocol for this research has been registered in the PROSPERO international database under registration number CRD42024532843. Articles that examined the association between perirenal fat and atherosclerosis, and reported correlation coefficients (r), beta coefficients (β), and odds ratios (ORs) in cross-sectional and case-control designs, involving adult or pediatric human populations, were included. The pooled ORs (95% CI), the log OR, and its standard error were calculated. Results: Following the identification of 10 eligible articles, meta-analysis and subgroup analysis were performed for different conditions, including adults, children, gender, atherosclerosis site, and comorbidity. One study reported the association between perirenal fat weight and atherosclerosis, while the remaining articles measured PRFT. The pooled estimated OR among 4767 adults was 1.24 (1.06–1.45) with I² = 83.6%. Among 929 adults, the pooled correlation coefficient (r) was 0.412 (p < 0.0001, I² = 63.3%). Among 1221 children, it was 0.291 (p < 0.0001, I² = 0%). Conclusion: PRFT is significantly associated with carotid intima-media thickness, suggesting its potential as a non-invasive biomarker of atherosclerosis. Further large-scale, longitudinal studies are needed to confirm its predictive value.
- 1 April 2025
- Published by SAGE Publications in Science Progress
- Vol. 108 (2)
Open AccessThe correlation of perirenal fat and atherosclerosis: A systematic review and meta-analysis
Objective: Finding accessible diagnostic tools for the diagnosis of atherosclerosis is necessary due to its rising incidence rate. The correlation of perirenal fat thickness (PRFT) and atherosclerosis has been investigated in previous studies using different imaging modalities including ultrasound and CT-scan, but their results have been equivocal. Therefore, we performed a systematic review and meta-analysis of observational studies to determine this potential correlation. Methods: This study is a systematic review and meta-analysis of observational studies. A comprehensive search was conducted up to 2 July 2024, across articles published in the Scopus, Web of Science, Cochrane Library, and PubMed databases. The protocol for this research has been registered in the PROSPERO international database under registration number CRD42024532843. Articles that examined the association between perirenal fat and atherosclerosis, and reported correlation coefficients (r), beta coefficients (β), and odds ratios (ORs) in cross-sectional and case-control designs, involving adult or pediatric human populations, were included. The pooled ORs (95% CI), the log OR, and its standard error were calculated. Results: Following the identification of 10 eligible articles, meta-analysis and subgroup analysis were performed for different conditions, including adults, children, gender, atherosclerosis site, and comorbidity. One study reported the association between perirenal fat weight and atherosclerosis, while the remaining articles measured PRFT. The pooled estimated OR among 4767 adults was 1.24 (1.06–1.45) with I² = 83.6%. Among 929 adults, the pooled correlation coefficient (r) was 0.412 (p < 0.0001, I² = 63.3%). Among 1221 children, it was 0.291 (p < 0.0001, I² = 0%). Conclusion: PRFT is significantly associated with carotid intima-media thickness, suggesting its potential as a non-invasive biomarker of atherosclerosis. Further large-scale, longitudinal studies are needed to confirm its predictive value.
- 1 May 2018
- Vol. 12 (3) , 185-189
Blood Pressure Measurement and Left Ventricular Mass Index in Hemodialysis Patients Comparison of Several Methods
Introduction. Systemic arterial hypertension is prevalent in endstage renal disease and is closely associated with left ventricular hypertrophy (LVH). Blood pressure (BP) behavior is unique in this population, and it is not clear which BP measurement should be used for treatment guidance. We aimed to evaluate the association of several methods of BP measurement with left ventricular mass index (LVMI) as hypertensive end-organ damage. Materials and Methods. Patients on maintenance hemodialysis, 3 or 4 times per week for at least 3 months, were enrolled. We compared the diagnostic value of 6 different methods of BP measurement, including predialysis, postdialysis, interdialysis, and standard BP measurements as well as ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring, based on LVMI as the gold standard. Results. Twenty patients, including 9 women and 11 men were enrolled. Ten patients (50%) had LVH and the others had normal LVMI (LVMI > 100 g/m(2) for women and > 131 100 g/m(2) for men). Only predialysis and postdialysis systolic BP values were significantly associated with LVMI (P = .02 and P = .02, respectively). Conclusions. Predialysis and postdialysis systolic BP values maybe reliable for detecting hypertension in hemodialysis patients, although according to previous data, the importance of self and ambulatory BP monitoring could not be overlooked.
- 1 May 2018
- Vol. 12 (3) , 185-189
Blood Pressure Measurement and Left Ventricular Mass Index in Hemodialysis Patients Comparison of Several Methods
Introduction. Systemic arterial hypertension is prevalent in endstage renal disease and is closely associated with left ventricular hypertrophy (LVH). Blood pressure (BP) behavior is unique in this population, and it is not clear which BP measurement should be used for treatment guidance. We aimed to evaluate the association of several methods of BP measurement with left ventricular mass index (LVMI) as hypertensive end-organ damage. Materials and Methods. Patients on maintenance hemodialysis, 3 or 4 times per week for at least 3 months, were enrolled. We compared the diagnostic value of 6 different methods of BP measurement, including predialysis, postdialysis, interdialysis, and standard BP measurements as well as ambulatory blood pressure monitoring (ABPM) and home blood pressure monitoring, based on LVMI as the gold standard. Results. Twenty patients, including 9 women and 11 men were enrolled. Ten patients (50%) had LVH and the others had normal LVMI (LVMI > 100 g/m(2) for women and > 131 100 g/m(2) for men). Only predialysis and postdialysis systolic BP values were significantly associated with LVMI (P = .02 and P = .02, respectively). Conclusions. Predialysis and postdialysis systolic BP values maybe reliable for detecting hypertension in hemodialysis patients, although according to previous data, the importance of self and ambulatory BP monitoring could not be overlooked.